Scarica l'app Stockscreener
38.01
20.86%
6.56
Pre-mercato:
38.21
0.20
+0.53%
Precedente Chiudi:
$31.45
Aprire:
$39.125
Volume 24 ore:
5.05M
Relative Volume:
5.33
Capitalizzazione di mercato:
$4.09B
Reddito:
-
Utile/perdita netta:
$-167.80M
Rapporto P/E:
-23.29
EPS:
-1.6323
Flusso di cassa netto:
$-144.07M
1 W Prestazione:
+22.65%
1M Prestazione:
+14.04%
6M Prestazione:
+118.83%
1 anno Prestazione:
+129.81%
Intervallo 1D:
$37.00
$39.96
Intervallo di 1 settimana:
$30.12
$39.96
Portata 52W:
$12.15
$39.96
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Compare EWTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
38.01 | 4.09B | 0 | -167.80M | -144.07M | -1.6323 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | Goldman | Neutral |
| 2025-07-30 | Iniziato | Raymond James | Strong Buy |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary - GlobeNewswire Inc.
Edgewise Therapeutics Stock Climbs On Catalyst-Rich Pipeline - timothysykes.com
50,000-share sale notice for EWTX (NASDAQ: EWTX) - Stock Titan
Edgewise Therapeutics CMO Donovan sells $2.09 million of stock - Investing.com
Edgewise Therapeutics (EWTX) CMO sells 55,230 shares under 10b5-1 plan - Stock Titan
CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits
Cytokinetics metrics satisfy in nHCM phase III - BioWorld News
Edgewise Therapeutics (EWTX) Explodes 23% on Pipeline Momentum and Strong Biotech Sentiment - International Business Times Australia
Edgewise Therapeutics stock hits 52-week high at $39.96 - Investing.com
Edgewise Therapeutics reports inducement grants as permitted by the Nasdaq Listing Rules - marketscreener.com
Edgewise Therapeutics Reports Inducement Grants As Permitted By The Nasdaq Listing Rules - TradingView
9 new Edgewise hires receive stock options for 266,000 shares - Stock Titan
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire
Avoiding Lag: Real-Time Signals in (EWTX) Movement - Stock Traders Daily
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Moody Aldrich Partners LLC Has $1.07 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Why Edgewise Therapeutics stock topped the market on Tuesday - MSN
Edgewise Therapeutics (NASDAQ:EWTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
This Edgewise Therapeutics Insider Reduced Their Stake By 63% - 富途牛牛
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Edgewise Therapeutics (NASDAQ: EWTX) holder Novo Holdings at 4.98% - Stock Titan
RBC Capital Remains a Buy on Edgewise Therapeutics (EWTX) - The Globe and Mail
EWTX Price Today: Edgewise Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $50 - Moomoo
[ARS] Edgewise Therapeutics, Inc. SEC Filing - Stock Titan
Edgewise Therapeutics (EWTX) outlines 2026 director elections, pay and auditor vote - Stock Titan
Edgewise Therapeutics (EWTX) Stock: What Investors Should Know | Q4 2025: Profit DisappointsStock Market Community - Cổng thông tin điện tử Tỉnh Sơn La
Discipline and Rules-Based Execution in EWTX Response - Stock Traders Daily
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Edgewise Therapeutics stock hits 52-week high at 34.03 USD By Investing.com - Investing.com Australia
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 1-Year HighStill a Buy? - MarketBeat
Edgewise Therapeutics stock hits 52-week high at 34.03 USD - Investing.com
Retail Surge: Can Edgewise Therapeutics Inc expand its profit marginsTrade Performance Summary & Risk Managed Trade Strategies - baoquankhu1.vn
Analysts Bullish on Edgewise Therapeutics Stock - National Today
What is the price target for Edgewise Therapeutics (EWTX) Stock | Price at $33.22, Up 1.22%Money Flow - Xã Thanh Hà
Bull Run: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Geopolitical Influence & Safe Entry Point Identification - baoquankhu1.vn
Behavioral Patterns of EWTX and Institutional Flows - Stock Traders Daily
Ideas Watch: Will Edgewise Therapeutics Inc stock hit new highs in YEARInsider Selling & Verified Short-Term Trading Plans - baoquankhu1.vn
History Review: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Opening Moves & Smart Investment Allocation Tips - baoquankhu1.vn
Aug Rallies: Can Edgewise Therapeutics Inc grow without dilutionWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Is Edgewise Therapeutics (EWTX) Stock Good for Short Term | Price at $33.00, Up 1.54%Fundamentals - UBND thành phố Hải Phòng
Aberdeen Group plc Increases Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Is Edgewise Therapeutics (EWTX) Stock Suitable for 2026 | Price at $32.50, Down 1.01%MA Crossover - Cổng thông tin điện tử tỉnh Tây Ninh
Aug Wrap: Is Edgewise Therapeutics Inc a cyclical or defensive stockMarket Activity Report & Weekly Stock Breakout Alerts - baoquankhu1.vn
Update Recap: Can Edgewise Therapeutics Inc reach all time highs this year2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
EWTX - Finviz
Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest - Sahm
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data - Sahm
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Breakouts Watch: Is Edgewise Therapeutics Inc subject to activist investor interest2026 Action & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Edgewise Therapeutics Inc Azioni (EWTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Donovan Joanne M. | CMO |
May 05 '26 |
Option Exercise |
7.08 |
50,000 |
354,000 |
54,367 |
| Donovan Joanne M. | CMO |
May 05 '26 |
Sale |
38.57 |
50,000 |
1,928,400 |
4,367 |
| Donovan Joanne M. | CMO |
May 04 '26 |
Sale |
31.29 |
5,230 |
163,663 |
4,367 |
| Donovan Joanne M. | CMO |
Apr 01 '26 |
Option Exercise |
7.08 |
28,662 |
202,927 |
38,259 |
| Donovan Joanne M. | CMO |
Apr 01 '26 |
Sale |
32.31 |
28,662 |
926,095 |
9,597 |
| Donovan Joanne M. | CMO |
Mar 31 '26 |
Option Exercise |
7.08 |
21,338 |
151,073 |
30,935 |
| Donovan Joanne M. | CMO |
Mar 31 '26 |
Sale |
32.12 |
21,338 |
685,308 |
9,597 |
| Donovan Joanne M. | CMO |
Mar 27 '26 |
Sale |
30.98 |
16,358 |
506,735 |
9,597 |
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):